Renaissance Technologies (RenTech)'s APGE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 562,000 shares of Apogee Therapeutics, Inc. (APGE) worth $1.84 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in APGE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 562,000 shares. Largest reduction occurred in Q3 2024, reducing 156,204 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Apogee Therapeutics (APGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Apogee Therapeutics (APGE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +562,000 | New Buy | 562,000 | $3.27 |
| Q3 2025 | -41,100 | Sold Out | 0 | $0.00 |
| Q2 2025 | +41,100 | New Buy | 41,100 | $43.43 |
| Q1 2025 | -11,500 | Sold Out | 0 | $0.00 |
| Q4 2024 | +11,500 | New Buy | 11,500 | $2.03 |
| Q3 2024 | -156,204 | Sold Out | 0 | $0.00 |
| Q2 2024 | +67,504 | Add 76.10% | 156,204 | $39.35 |
| Q1 2024 | +88,700 | New Buy | 88,700 | $66.45 |
Renaissance Technologies (RenTech)'s Apogee Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Apogee Therapeutics, Inc. (APGE) in Q1 2024, acquiring 88,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Apogee Therapeutics, Inc. (APGE) for 8 quarters since Q1 2024.
Renaissance Technologies (RenTech)'s largest addition to Apogee Therapeutics, Inc. (APGE) was in Q1 2026, adding 562,000 shares worth $1.84 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 562,000 shares of Apogee Therapeutics, Inc. (APGE), valued at approximately $1.84 M.
As of the Q1 2026 filing, Apogee Therapeutics, Inc. (APGE) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Apogee Therapeutics, Inc. (APGE) was 562,000 shares, as reported at the end of Q1 2026.